Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: A cohort study

Breast Cancer Research and Treatment

Volumn 138, Issue 3, 2013, Pages 951-959

  Contiero, Paolo ^a   Berrino, Franco ^a   Tagliabue, Giovanna ^a   Mastroianni, Antonio ^a   Di Mauro, Maria Gaetana ^a   Fabiano, Sabrina ^a   Annulli, Monica ^b   Muti, Paola ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Chemistry Unit   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

BMI; Breast cancer; Fasting glucose; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; GLUCOSE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ITALY; MAJOR CLINICAL STUDY; METASTASIS; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; CONFIDENCE INTERVALS; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84877840118     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2519-9     Document Type: Article

References (34)

1. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
2. Koroljow S (1962) Two cases of malignant tumors with metastases apparently treated successfully with hypoglycemic coma. Psychiatr Q 36:261-270
3. Carroll KK (1977) Dietary factors in hormone-dependent cancers. Curr Concepts Nutr 6:25-40
4. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11(11):1361-1368
5. Sieri S, Muti P, Claudia A, Berrino F, Pala V, Grioni S, Abagnato CA, Blandino G, Contiero P, Schunemann HJ, Krogh V (2012) Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 130(4):921-929
6. Holmes MD, Liu S, Hankinson SE, Colditz GA, Hunter DJ, Willett WC (2004) Dietary carbohydrates, fiber, and breast cancer risk. Am J Epidemiol 159(8):732-739
7. Miao Jonasson J, Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjörnsdottir S (2012) HbA1C and cancer risk in patients with type 2 diabetes-a nationwide population-based prospective cohort study in Sweden. PLoS One 7(6):e38784. doi: 10.1371/journal.pone.0038784
8. Garber K (2004) Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 96(24):1805-1806
9. Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24(2):68-72
10. Sun Y (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med 8(6):583-599
11. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445
12. Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202(3):654-662
13. Krzeslak A, Wojcik-Krowiranda K, Forma E, Jozwiak P, Romanowicz H, Bienkiewicz A, Brys M (2012) Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers. Pathol Oncol Res 18(3):721-728
14. Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, Morgan A, Winters ZE, Foulstone EJ, Shield JP, Perks CM (2010) Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase. Endocr Relat Cancer 17(2):539-551
15. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119(1):236-238
16. Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML (2011) Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev 20(5):890-899
17. Krone CA, Ely JT (2005) Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 4(1):25-31
18. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30(2):164-171
19. Contiero P, Tittarelli A, Tagliabue G, Maghini A, Fabiano S, Crosignani P, Tessandori R (2005) The EpiLink record linkage software: presentation and results of linkage test on cancer registry files. Methods Inf Med 44(1):66-71
20. Tagliabue G, Maghini A, Fabiano S, Tittarelli A, Frassoldi E, Costa E, Nobile S, Codazzi T, Crosignani P, Tessandori R, Contiero P (2006) Consistency and accuracy of diagnostic cancer codes generated by automated registration: comparison with manual registration. Popul Health Metr 4:10
21. Therneau TM, Grambsch PM (2000) Testing proportional hazards. In: Modeling survival data: extending the Cox model. Springer, New York
22. Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V, Mathoulin-Pélissier S (2010) Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol 10:20
23. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V (2002) A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 7(1):83-104
24. Freedman LS, Schatzkin A (1992) Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol 136(9):1148-1159
25. R Development Core Team (2007), R: a language and environment for statistical computing. http://www.r-project.org
26. Ewertz M, Jensen MB, Gunnarsdóttir KÁ, Højris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S (2011) Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 29(1):25-31
27. de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JP, Vicente M, Giuliani R, Nordenskjöld B, Gutiérez J, Andersson M, Vila MM, Jakesz R, Demol J, Dewar J, Santoro A, Lluch A, Olsen S, Gelber RD, Di Leo A, Piccart-Gebhart M (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat 119(1):145-153
28. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627-633
29. Monteiro CA, Cannon G (2012) The impact of transnational "big food" companies on the South: a view from Brazil. PLoS Med 9(7):e1001252. doi: 10.1371/journal.pmed.1001252
30. Igumbor EU, Sanders D, Puoane TR, Tsolekile L, Schwarz C, Purdy C, Swart R, Durão S, Hawkes C (2012) "Big food," the consumer food environment, health, and the policy response in South Africa. PLoS Med 9(7):e1001253. doi: 10.1371/journal.pmed.1001253
31. Stuckler D, McKee M, Ebrahim S, Basu S (2012) Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med 9(6):e1001235. doi: 10.1371/journal.pmed.1001235
32. Wang H, Wang J, Liu MM, Wang D, Liu YQ, Zhao Y, Huang MM, Liu Y, Sun J, Dong GH (2012) Epidemiology of general obesity, abdominal obesity and related risk factors in urban adults from 33 communities of northeast china: the CHPSNE study. BMC Public Health 12:967
33. Levy RB, Claro RM, Bandoni DH, Mondini L, Monteiro CA (2012) Availability of added sugars in Brazil: distribution, food sources and time trends. Rev Bras Epidemiol 15(1):3-12
34. World Health Organization (2006) Obesity and overweight. Fact sheet number 311. World Health Organization, Geneva